PlainPharmaWatch

CMS Open Payments · Program Year 2024

Genzyme Corporation

Genzyme Corporation reported $97,001,722.56 in payments to 182,526 physicians and teaching hospitals across 185,572 transactions.

See the rankings → How this is sourced
$97.0M
Total payments
185,572
Transactions
182,526
Recipients
+$10.8M
General Payments vs PY2023

Genzyme Corporation reported $97,001,722.56 in payments to 182,526 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #28 of 1,925 reporting manufacturers (0.7% of all US industry payments), averaging $531.44 per recipient across 9 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Genzyme Corporation pairs top-5% payment volume with a broadly spread payment pattern across many recipients.

#28
of 1,925 companies
0.7%
of all US industry payments
0.3%
paid to its single top recipient
9
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Genzyme Corporation's CMS-reported General Payments increased by $10.8M (+23.0%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: GENZYME CORPORATIONPY2023: GENZYME CORPORATIONPY2024: GENZYME CORPORATION. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$46.9MPY2024$57.6M
PY2023
$46,855,160.87
PY2024
$57,615,505.18

How Genzyme Corporation ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Genzyme Corporation's total vs. every reporting company

CMS Open Payments, Program Year 2024

$97,001,723 Top 1% higher than 99% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Below this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Below this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Below this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). This entry sits in this band. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Genzyme Corporation

Averaging $522.72 per transaction and $531.44 per recipient, Genzyme Corporation's Program Year 2024 total comes to $97,001,722.56 across 185,572 transactions and 182,526 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #28 of 1,925 companies, representing 0.7% of all industry payments reported nationwide for the year.

"Compensation for Services Other Than Consulting" leads the 9-category general-payment breakdown below at $22.0M (22.7% of the company's reported total, 5,224 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 9 types of general payments, Genzyme Corporation's largest category was "Compensation for Services Other Than Consulting" at $22.0M - 22.7% of the company's reported total.

How Genzyme Corporation divides its payments

General-payment categories, ordered by reported total

1. Compensation for Services…$22.0M2. Royalty or License$16.0M3. Consulting Fee$8.0M4. Food and Beverage$5.6M5. Travel and Lodging$3.2M6. Grant$1.5M7. Charitable Contribution$930.5K8. Space Rental or Facility …$323.4K9. Education$3.5K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $22.0M 5,224
Royalty or License $16.0M 4
Consulting Fee $8.0M 1,651
Food and Beverage $5.6M 168,437
Travel and Lodging $3.2M 6,957
Grant $1.5M 52
Charitable Contribution $930.5K 8
Space Rental or Facility Fees $323.4K 140
Education $3.5K 53

Recipient Concentration in General Payments

The five largest recipient relationships account for $17,837,201.90 (31.0%) of $57,615,505.18 in this company's General Payments records across 48,671 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Genzyme Corporation

The five named recipients with the highest reported General Payments from this company

Univ Of Mi Hospitals & Hlth …$16.0MChildrens Hospital Corporati…$927.0KDonald Glass$330.1KBrigham And Womens Hospital$311.1KRaj Chovatiya$253.4K
  1. 1

    Univ Of Mi Hospitals & Hlth Ctrs

    $16,015,579.00 across 11 reported transactions

  2. 2

    Childrens Hospital Corporation

    $927,050.00 across 7 reported transactions

  3. 3

    Donald Glass

    $330,071.45 across 2 reported transactions

  4. 4

    Brigham And Womens Hospital

    $311,125.00 across 3 reported transactions

  5. 5

    Raj Chovatiya

    $253,376.45 across 120 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $522.72. Average per recipient: $531.44.

Total Amount

$97,001,722.56

Avg per Transaction

$522.72

Avg per Recipient

$531.44

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Genzyme Corporation Share

0.7%

#28 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Genzyme Corporation

Boston Scientific Corporation

$99.8M 271,484 recipients

Edwards Lifesciences Corporation

$93.0M 70,149 recipients

DePuy Synthes Products, Inc.

$101.4M 2,547 recipients

Abbott Laboratories

$91.7M 292,558 recipients

Celgene Corporation

$88.9M 60,850 recipients

Zimmer Biomet Holdings, Inc.

$88.6M 33,496 recipients

Frequently Asked Questions

How much did Genzyme Corporation pay to physicians and hospitals in 2024? ▾
Genzyme Corporation made $97,001,722.56 in payments to physicians and hospitals in Program Year 2024, across 185,572 individual transactions. This represents 0.7% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Genzyme Corporation? ▾
Genzyme Corporation made payments to 182,526 physicians and teaching hospitals in 2024. The average payment per recipient was $531.44.
What types of payments did Genzyme Corporation make? ▾
Genzyme Corporation made 9 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Compensation for Services Other Than Consulting" at $22.0M, representing 22.7% of the company's reported total.
How does Genzyme Corporation rank among pharmaceutical companies? ▾
Out of 1,925 companies in the CMS Open Payments database for 2024, Genzyme Corporation ranks #28 by total payment amount.
What is the average payment size from Genzyme Corporation? ▾
In 2024, Genzyme Corporation averaged $522.72 per transaction across 185,572 transactions to 182,526 recipients.
Where does the payment data for Genzyme Corporation come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Genzyme Corporation's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.